Related Experiment Videos
Knowledge representation model for systems-level analysis of signal transduction networks
Dong-Yup Lee1, Ralf Zimmer, Sang-Yup Lee
1Department of Chemical and Biomolecular Engineering and Bioinformatics Research Center, Korea Advanced Institute of Science and Technology, 373-1 Guseong-dong, Yuseong-gu, Daejeon 305-701, Republic of Korea. dylee@pse.kaist.ac.kr
Genome Informatics. International Conference on Genome Informatics
|February 12, 2005
Summary
A novel Petri-net model formally represents cell signaling pathways and their diseases. This framework aids in understanding complex networks, like those involving cytokines, for drug discovery.
Area of Science:
- Systems Biology
- Computational Biology
- Molecular Biology
Background:
- Cell signaling pathways are complex and crucial for cellular functions.
- Pathological implications of dysregulated signaling are not fully understood.
- Formal modeling can aid in deciphering intricate molecular mechanisms.
Purpose of the Study:
- To develop a formal, Petri-net based model for knowledge representation of cell signaling.
- To establish a framework for reconstructing and analyzing signal transduction networks.
- To explore the mechanisms of complex signaling networks and their pathological relevance.
Main Methods:
- Development of a Petri-net based model for formal knowledge representation.
- Construction of a conceptual framework for signal transduction network analysis.
- Application of the framework to the signaling networks induced by Interleukin-1 beta (IL-1β) and Tumor Necrosis Factor-alpha (TNF-α).
Main Results:
- A formal model successfully represents molecular mechanisms of cell signaling.
- The framework enables qualitative understanding of system-level cell signaling behavior.
- Detailed analysis of expert-knowledge networks for IL-1β and TNF-α signaling was performed.
Conclusions:
- The developed Petri-net model provides a formal approach to studying cell signaling.
- The conceptual framework facilitates the analysis of complex signal transduction networks.
- This strategy shows promise for identifying and validating drug targets in diseases involving aberrant cell signaling.